comparemela.com

Latest Breaking News On - Nasdaq govx - Page 2 : comparemela.com

Head to Head Survey: Santhera Pharmaceuticals (OTCMKTS:SPHDF) versus GeoVax Labs (NASDAQ:GOVX)

GeoVax Labs (NASDAQ:GOVX – Get Free Report) and Santhera Pharmaceuticals (OTCMKTS:SPHDF – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, valuation, risk and analyst recommendations. Earnings & Valuation This table compares GeoVax Labs […]

Comparing GeoVax Labs (NASDAQ:GOVX) & Belite Bio (NASDAQ:BLTE)

GeoVax Labs (NASDAQ:GOVX – Free Report) and Belite Bio (NASDAQ:BLTE – Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability. Volatility and Risk GeoVax Labs has a beta of […]

Comparing GeoVax Labs (NASDAQ:GOVX) & Tyra Biosciences (NASDAQ:TYRA)

GeoVax Labs (NASDAQ:GOVX – Get Rating) and Tyra Biosciences (NASDAQ:TYRA – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, risk, earnings and profitability. Risk & Volatility GeoVax Labs has a beta of […]

Brokers Set Expectations for GeoVax Labs, Inc s Q4 2023 Earnings (NASDAQ:GOVX)

GeoVax Labs, Inc. (NASDAQ:GOVX – Get Rating) – Equities research analysts at HC Wainwright boosted their Q4 2023 earnings per share estimates for shares of GeoVax Labs in a report released on Monday, May 8th. HC Wainwright analyst V. Bernardino now anticipates that the company will post earnings per share of $0.23 for the quarter, […]

Susquehanna International Group LLP Buys Shares of 40,961 GeoVax Labs, Inc (NASDAQ:GOVX)

Susquehanna International Group LLP bought a new stake in GeoVax Labs, Inc. (NASDAQ:GOVX – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 40,961 shares of the company’s stock, valued at approximately $26,000. Other hedge funds and other institutional investors also recently […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.